Novo Nordisk: Navigating Political Landscapes

This chapter explores how political decisions, particularly regarding tariffs, affect Novo Nordisk's operations in the pharmaceutical industry. It highlights the company's investments in U.S. manufacturing and its strategy to bolster domestic production while seeking growth through partnerships in the obesity and diabetes sectors.